"During the flames of controversy, opinions, mass disputes, conflict, and world news, sometimes the most precious, refreshing, peaceful words to hear amidst all the chaos are simply and humbly 'I don't know.” ? Criss Jami
Today we check back in on the progress of a small developmental concern and 'Busted IPO'.
Company Overview:
Syros Pharmaceuticals (SYRS) IPO’d in 2016 and is a Massachusetts-based company that is focused on understanding the non-coding regulatory region of the genome in order to advance novel medicines that control the expression of genes. Some diseases come about